35.07
1.51%
0.52
アフターアワーズ:
35.50
0.43
+1.23%
前日終値:
$34.55
開ける:
$34.6
24時間の取引高:
2.54M
Relative Volume:
0.71
時価総額:
$5.46B
収益:
$264.79M
当期純損益:
$-14.36M
株価収益率:
-125.25
EPS:
-0.28
ネットキャッシュフロー:
$67.82M
1週間 パフォーマンス:
+18.72%
1か月 パフォーマンス:
+44.62%
6か月 パフォーマンス:
+98.14%
1年 パフォーマンス:
+176.80%
Tg Therapeutics Inc Stock (TGTX) Company Profile
名前
Tg Therapeutics Inc
セクター
電話
(212) 554-4484
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
TGTX | 35.07 | 5.46B | 264.79M | -14.36M | 67.82M | -0.28 |
VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-08-02 | アップグレード | Goldman | Sell → Neutral |
2023-06-26 | 再開されました | Jefferies | Buy |
2022-05-20 | 開始されました | BofA Securities | Underperform |
2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
2021-04-20 | 開始されました | Goldman | Neutral |
2021-04-19 | 繰り返されました | H.C. Wainwright | Buy |
2020-09-01 | 開始されました | JP Morgan | Overweight |
2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
2020-06-05 | 開始されました | Evercore ISI | Outperform |
2020-01-17 | 繰り返されました | H.C. Wainwright | Buy |
2019-11-27 | 再開されました | B. Riley FBR | Buy |
2019-02-06 | 再開されました | Jefferies | Buy |
2018-09-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
2018-03-09 | 繰り返されました | B. Riley FBR, Inc. | Buy |
2017-12-01 | 再開されました | B. Riley FBR, Inc. | Buy |
2017-11-14 | 再開されました | H.C. Wainwright | Buy |
2017-04-25 | 開始されました | Jefferies | Buy |
2017-03-06 | 繰り返されました | FBR & Co. | Outperform |
2016-10-06 | 再開されました | Brean Capital | Buy |
2016-05-27 | 開始されました | SunTrust | Buy |
2015-12-01 | 開始されました | FBR Capital | Outperform |
2015-09-09 | 開始されました | Raymond James | Strong Buy |
2015-08-12 | 再開されました | H.C. Wainwright | Buy |
2015-06-19 | 繰り返されました | Brean Capital | Buy |
2014-12-11 | 繰り返されました | ROTH Capital | Buy |
2014-12-10 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Tg Therapeutics Inc (TGTX) 最新ニュース
NYC biotech venture tops Deloitte's Technology Fast 500 - The Business Journals
TG Therapeutics Stock Soars Nearly 15% After Topping Deloitte's Fast 500 and Raising Revenue Outlook - GuruFocus.com
A Closer Look at TG Therapeutics's Options Market Dynamics - Benzinga
Deloitte Unveils 2024 North America Technology Fast 500™ Rankings - The Malaysian Reserve
TG Therapeutics Claims #1 Spot on Deloitte Fast 500 List, Driven by MS Drug Success | TGTX Stock News - StockTitan
TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte - The Bakersfield Californian
TG Therapeutics Ranked Number One Fastest-Growing Company - GlobeNewswire
TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ - Yahoo Finance
Oppenheimer & Co. Inc. Invests $759,000 in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
When (TGTX) Moves Investors should Listen - Stock Traders Daily
Entropy Technologies LP Purchases Shares of 31,200 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Principal Financial Group Inc. Raises Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Amalgamated Bank - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Los Angeles Capital Management LLC - MarketBeat
Insider Sale: Director Sagar Lonial Sells 5,000 Shares of TG The - GuruFocus.com
Insider Sale: Director Laurence Charney Sells 25,000 Shares of T - GuruFocus.com
New York State Teachers Retirement System Invests $1 Million in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Don't Ignore The Insider Selling In TG Therapeutics - Simply Wall St
TG Therapeutics stock hits 52-week high at $28.43 - Investing.com India
TG Therapeutics stock hits 52-week high at $28.43 By Investing.com - Investing.com Canada
FY2024 EPS Estimates for TG Therapeutics Raised by Analyst - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Sets New 1-Year HighWhat's Next? - MarketBeat
FY2027 EPS Forecast for TG Therapeutics Decreased by Analyst - MarketBeat
Optimistic Investors Push TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Up 27% But Growth Is Lacking - Simply Wall St
TG Therapeutics, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
FY2024 EPS Estimates for TG Therapeutics Lowered by Analyst - MarketBeat
HC Wainwright Boosts Earnings Estimates for TG Therapeutics - MarketBeat
TG Therapeutics Inc (TGTX) Q3 2024 Earnings: Revenue Hits $83.3M, EPS at $0.02, Surpassing Estimates - GuruFocus.com
HC Wainwright Increases TG Therapeutics (NASDAQ:TGTX) Price Target to $55.00 - MarketBeat
TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates (NASDAQ:TGTX) - Seeking Alpha
TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $22.00 at The Goldman Sachs Group - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Announces Earnings Results - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2024 Earnings Call Transcript - Insider Monkey
TG Therapeutics price target raised to $45 from $43 at Ladenburg - TipRanks
TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Rec - GuruFocus.com
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Earnings call: TG Therapeutics reports robust growth for BRIUMVI - Investing.com
TG Therapeutics: Q3 Earnings Snapshot - Darien Times
Earnings call: TG Therapeutics reports robust growth for BRIUMVI By Investing.com - Investing.com UK
TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here’s Why Shares Fell - Seeking Alpha
TG Therapeutics (TGTX) Lags Q3 Earnings Estimates - MSN
(TGTX) Trading Advice - Stock Traders Daily
FUJIFILM Diosynth Biotechnologies To Manufacture TG Therapeutics' MS Drug - Contract Pharma
TG Therapeutics (NASDAQ:TGTX) Shares Gap DownHere's What Happened - MarketBeat
Morning Brew: Nvidia Joins Dow, Fed Rate Cut Looms, and TG Thera - GuruFocus.com
FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics - The Manila Times
Tg Therapeutics Inc (TGTX) 財務データ
収益
当期純利益
現金流量
EPS
Tg Therapeutics Inc (TGTX) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Charney Laurence N | Director |
Nov 11 '24 |
Sale |
30.20 |
25,000 |
754,875 |
212,479 |
大文字化:
|
ボリューム (24 時間):